Classifying the severity of bullous pemphigoid disease

Affiliations

Comment

C Blome et al. Br J Dermatol. 2021 Jun.

. 2021 Jun;184(6):997-998.

doi: 10.1111/bjd.19830. Epub 2021 Feb 18.

¹ Institute for Health Services Research in Dermatology and Nursing, University Medical Center Hamburg-Eppendorf, Martinistraße 52, Hamburg, 20246, Germany.

No abstract available

Comment on

International validation of the Bullous Pemphigoid Disease Area Index severity score and calculation of cut-off values for defining mild, moderate and severe types of bullous pemphigoid.
Masmoudi W, Vaillant M, Vassileva S, Patsatsi A, Quereux G, Moltrasio C, Abasq C, Prost-Squarcioni C, Kottler D, Kiritsi D, Litrowski N, Plantin P, Friedrichsen L, Zebrowska A, Duvert-Lehembre S, Hofmann S, Ferranti V, Jouen F, Joly P, Hebert V; EADV Autoimmune Bullous Skin Disease Task Force. Masmoudi W, et al. Br J Dermatol. 2021 Jun;184(6):1106-1112. doi: 10.1111/bjd.19611. Epub 2020 Nov 29. Br J Dermatol. 2021. PMID: 33067805

1. Langan SM, Smeeth L, Hubbard R et al. Bullous pemphigoid and pemphigus vulgaris - incidence and mortality in the UK: population based cohort study. BMJ 2008; 337:a180.
1. Bernard P, Antonicelli F. Bullous pemphigoid: a review of its diagnosis, associations and treatment. Am J Clin Dermatol 2017; 18:513-28.
1. Murrell DF, Daniel BS, Joly P et al. Definitions and outcome measures for bullous pemphigoid: recommendations by an international panel of experts. J Am Acad Dermatol 2012; 66:479-85.
1. Masmoudi W, Vaillant M, Vassileva S et al. International validation of the Bullous Pemphigoid Disease Area Index severity score and calculation of cut-off values for defining mild, moderate and severe types of bullous pemphigoid. Br J Dermatol 2021; https://doi.org/10.1111/bjd.19611
1. Wijayanti A, Zhao CY, Boettiger D et al. The reliability, validity and responsiveness of two disease scores (BPDAI and ABSIS) for bullous pemphigoid: which one to use? Acta Derm Venereol 2017; 97:24-31.